Mizuho analyst Anthony Petrone initiated coverage of DexCom (DXCM) with an Outperform rating and $85 price target The firm cites its positive ...

Discussions at the Advanced Technologies & Treatments for Diabetes meeting covered CGM use in non–insulin-treated people with ...

Dexcom has filed an application with the FDA for a 15-day version of its G7 continuous glucose monitor. The company does not ...

Medtronic (NYSE:MDT) has appointed a former Dexcom leader as the new head of Americas for its Diabetes business unit.

As of today, the Government of Saskatchewan’s expanded public coverage for continuous glucose monitoring (CGM) systems comes into effect. Dexcom, Inc. (NASDAQ: DXCM), a global leader in real ...

The general mood among these heavyweight investors is divided, with 12% leaning bullish and 50% bearish. Among these notable ...

Eligible residents living with diabetes in Saskatchewan who rely on any type of insulin may be eligible to receive coverage for Dexcom’s continuous glucose monitoring systems.* BURNABY, British ...

BURNABY, British Columbia--(BUSINESS WIRE)-- As of today, the Government of Saskatchewan’s expanded public coverage for continuous glucose monitoring (CGM) systems comes into effect. Dexcom, Inc ...

As of today, the Government of Saskatchewan’s expanded public coverage for continuous glucose monitoring (CGM) systems comes ...